The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
PTEN loss in the continuum of common cancers, rare syndromes and mouse models
Open accessAbstract
PTEN is among the most frequently inactivated tumour suppressor genes in sporadic cancer. PTEN has dual protein and lipid phosphatase activity, and its tumour suppressor activity is dependent on its lipid phosphatase activity, which negatively regulates the PI3K–AKT–mTOR pathway. Germline mutations in PTEN have been described in a variety of rare syndromes that are collectively known as the PTEN hamartoma tumour syndromes (PHTS). Cowden syndrome is the best-described syndrome within PHTS, with approximately 80% of patients having germline PTEN mutations. Patients with Cowden syndrome have an increased incidence of cancers of the breast, thyroid and endometrium, which correspond to sporadic tumour types that commonly exhibit somatic PTEN inactivation. Pten deletion in mice leads to Cowden syndrome-like phenotypes, and tissue-specific Pten deletion has provided clues to the role of PTEN mutation and loss in specific tumour types. Studying PTEN in the continuum of rare syndromes, common cancers and mouse models provides insight into the role of PTEN in tumorigenesis and will inform targeted drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–210 of 210
Shao, J., Washington, M. K., Saxena, R., & Sheng, H. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm186 · Cited by 41
Puxeddu, E., Zhao, G., Stringer, J. R., Medvedovic, M., Moretti, S., & Fagin, J. A. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.09.010 · Cited by 36
Poon, J. S., Eves, R. L., & Mak, A. S. (2010) · Cell Cycle · doi:10.4161/cc.9.22.13936 · Cited by 34
Pezzolesi, M. G., Li, Y., Zhou, X.-P., Pilarski, R., Shen, L., & Eng, C. (2006) · The American Journal of Human Genetics · doi:10.1086/508943 · Cited by 34
PTEN gene loss, but not mutation, in benign and malignant phaeochromocytomas
van Nederveen, F. H., Perren, A. A., Dannenberg, H., Petri, B., Dinjens, W. N. M., Komminoth, P., & de Krijger, R. R. (2006) · The Journal of Pathology · doi:10.1002/path.1968 · Cited by 32
Reduction of Pten dose leads to neoplastic development in multiple organs of Pten shRNA mice
Shen-Li, H., Koujak, S., Szablocs, M., & Parsons, R. E. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.11.13814 · Cited by 29
Mutation Analysis of the Putative Tumor Suppressor GenePTEN/MMAC1in Hepatocellular Carcinoma
Yeh, K.-T., Chang, J., Chen, Y., Chen, S., Yu, S., Shih, M., Perng, L.-L., Wang, J., Tsai, M., & Chang, C. (2000) · Cancer Investigation · doi:10.3109/07357900009038243 · Cited by 27
Strain-Specific Spontaneous and NNK-Mediated Tumorigenesis in Pten+/− Mice
Hollander, M. C., Balogh, A., Liwanag, J., Han, W., Linnoila, R. I., Anver, M. R., & Dennis, P. A. (2008) · Neoplasia · doi:10.1593/neo.08406 · Cited by 24
Self-citationHoff, D., LoRusso, P. M., Tibes, R., Shapiro, G. I., Weiss, G. J., Ware, J. A., Fredrickson, J., Mazina, K. E., Levy, G. G., & Wagner, A. J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.2541 · Cited by 20
VHL and PTEN loss coordinate to promote mouse liver vascular lesions
Chen, S., Sanford, C. A., Sun, J., Choi, V. W., Dyke, T. V., Samulski, R. J., & Rathmell, W. K. (2010) · Angiogenesis · doi:10.1007/s10456-010-9164-2 · Cited by 11
Cited by
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
The functions and regulation of the PTEN tumour suppressor
Song, M. S., Salmena, L., & Pandolfi, P. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3330 · Cited by 1,926
Phosphoinositides: Tiny Lipids With Giant Impact on Cell Regulation
Balla, T. (2013) · Physiological Reviews · doi:10.1152/physrev.00028.2012 · Cited by 1,638
A compendium of mutational cancer driver genes
Martínez-Jiménez, F., Muiños, F., Sentís, I., Deu-Pons, J., Reyes-Salazar, I., Arnedo-Pac, C., Mularoni, L., Pich, O., Bonet, J., Kranas, H., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0290-x · Cited by 1,296
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Zhang, L., Zhang, S., Yao, J., Lowery, F. J., Zhang, Q., Huang, W.-C., Li, P., Li, M., Wang, X., Zhang, C., et al. (2015) · Nature · doi:10.1038/nature15376 · Cited by 1,175
Metadata
- Authors
- Hollander, M. C., Blumenthal, G. M., & Dennis, P. A.
- Venue
- Nature Reviews Cancer
- Published
- 2011-03-24
- Volume
- 11
- Issue
- 4
- Pages
- 289-301
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1996222881
- Cited by
- 794
- References
- 210
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.